Clinical Trial

Prognostic Value of the AMR Measured After PPCI in STEMI Patients

Study acronym: EARLYMYOAMR
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to learn about in STEMI with Primary PCI Patients. The main questions it aims to answer are: * To determine the value of AMR in predicting the long-term clinical prognosis of patients with STEMI after PPCI, and to find the best cut-off value. * Analyze the factors of PPCI affecting AMR and explore the effective measures of PPCI microcirculation protection. Radiographic images of STEMI receiving primary PCI treatment in several chest pain centers in China will be included. The last image of the infarct-related vessel will be used as a target to calculate its AMR. The relationship between AMR and long-term clinical prognosis was analyzed.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-12-14; most recent amendment 2025-03-12.
Status change: Recruiting → Active, Not Recruiting 2025-03-12
Status change: Not Yet Recruiting → Recruiting 2023-02-20
Trial Details
NCT Number NCT05653765
Lead Sponsor Henan Institute of Cardiovascular Epidemiology
Conditions Coronary Heart Disease, ST Elevation Myocardial Infarction
Enrollment 2,663 participants
Start Date 2022-12-20
Primary Completion 2023-12-20 (estimated)
Study Completion 2025-03-20 (estimated)
Updated on ClinicalTrials.gov 2025-03-17